TNXP TONIX PHARMACEUTICALS HOLDING CORP Investments/Divestments 8-K Filing 2023 - Clinical Trials Update Tonix Pharmaceuticals announced the elimination of interim analyses in two clinical trials and updated its investor presentation.Get access to all SEC 8-K filings of the TONIX PHARMACEUTICALS HOLDING CORP